IGHG1 and cervical cancer: To further investigate whether IGHG1 deficiency inhibited the TLR4 signaling pathways in cervical cancer cells, we examined nuclear translocation of NF-κB subunit p65 in Hela cells with immunostaining after LPS treatment.